Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 4:39 PM
Ignite Modification Date:
2025-12-24 @ 4:39 PM
NCT ID:
NCT05493566
Brief Title:
Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer
Official Title:
A Biomarker Study of Low-Dose IL-2 Plus Pembrolizumab in Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC)
Study:
NCT05493566
Protocol Section:
NCT05493566